I am in clinical practice. I lead a research team to help healthcare providers develop online, point-of-care prognostics tools to enhance care and provide clinical decision support. My team helps you to extract prediction from anonymized data to provide more personalized care to your patients. Dr. Mylene W.
M. Yao is Co-founder and CEO of Univfy Inc., a company that develops
personalized prognostics for fertility patients and physicians. In her previous roles as National Institute of
Health (NIH)-funded principal investigator and faculty at Stanford University,
Dr. Yao, together with her scientific collaborator and co-founder Professor
Wing H. Wong, and their research teams, developed IVF
prediction models that could personalize success rates for IVF patients. She co-founded Univfy Inc. to translate that
research into user-friendly online
prediction tests to bring personalized prediction to patients and doctors.
Dr. Yao has
over fifteen years of experience in research in reproductive medicine, and
embryo and uterine biology with publications in clinical and basic science
research journals, including Fertility
and Sterility, the Proceedings of the National Academy of Sciences, Molecular
Endocrinology, Developmental Biology, and Molecular Systems Biology.
received her medical degree from the University of Toronto, Canada, in 1993,
and completed her residency training in obstetrics and gynecology at McGill
University, Montreal, Canada, in 1998.
She received her clinical subspecialty training in reproductive
endocrinology and infertility and post-doctoral training in development biology
in the laboratory of Dr Richard L Maas, at Brigham and Women’s Hospital, Harvard
University, Boston, MA, in 1998–2001. In
2003, she joined the faculty at Stanford University to lead basic science research
on early embryo development.